News Statement on Pfizer’s withdrawal of new sickle cell treatment, Voxelotor (OXBRYTA®) 26 Sep 2024 We are deeply shocked and extremely disappointed by Pfizer’s sudden decision to withdraw Voxelotor (OXBRYTA®)... Read More
